Position in TSHA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$96,999,000
-$22,351,000 QoQ
Shares Held
21,700,000
0.0% QoQ
Ownership
7.55%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Avoro Capital Advisors LLC holds $8,549,473,651 across 28 Biotechnology names. TSHA ranks #19 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
5,062,500 | $1,157,945,625 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,818,181 | $951,763,208 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
2,888,888 | $746,257,548 | |
| 4 | ARGX |
Argenx SE
|
1,000,000 | $730,250,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,699,999 | $670,889,937 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
7,474,747 | $622,571,677 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
12,222,222 | $491,699,991 | |
| 8 | CNTA |
Centessa Pharmaceuticals plc
|
11,430,455 | $454,017,672 |
All Filings in TSHA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $96,999,000 | 21,700,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $119,350,000 | 21,700,000 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $70,959,000 | 21,700,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $50,127,000 | 21,700,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $27,799,998 | 19,999,999 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $34,599,998 | 19,999,999 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,486,500 | 18,650,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $41,776,000 | 18,650,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $53,525,500 | 18,650,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,709,332 | 4,355,555 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,403,000 | 3,925,000 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||